Article FDA Thank You FDA gives companies leeway to go after misinformation, but not free reign
Agency IQ
JULY 12, 2024
those sold under authorization from a licensed provider or other regulatory-specific situations) and is submitted as part of the medical device’s listing (general controls), and the agency may request a copy of all advertising materials for good cause ( See a Congressional Research Service explainer on this topic here ).
40 
Let's personalize your content